Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Humidity-regulated CLCA2 protects the epidermis from hyperosmotic stress.

Seltmann K, Meyer M, Sulcova J, Kockmann T, Wehkamp U, Weidinger S, Auf dem Keller U, Werner S.

Sci Transl Med. 2018 May 9;10(440). pii: eaao4650. doi: 10.1126/scitranslmed.aao4650.

PMID:
29743348
2.

A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents.

Herter S, Morra L, Schlenker R, Sulcova J, Fahrni L, Waldhauer I, Lehmann S, Reisländer T, Agarkova I, Kelm JM, Klein C, Umana P, Bacac M.

Cancer Immunol Immunother. 2017 Jan;66(1):129-140. doi: 10.1007/s00262-016-1927-1. Epub 2016 Nov 17.

3.

Antitumour activity of the glycoengineered type II anti-CD20 antibody obinutuzumab (GA101) in combination with the MDM2-selective antagonist idasanutlin (RG7388).

Herting F, Herter S, Friess T, Muth G, Bacac M, Sulcova J, Umana P, Dangl M, Klein C.

Eur J Haematol. 2016 Nov;97(5):461-470. doi: 10.1111/ejh.12756. Epub 2016 Apr 18.

PMID:
26993060
4.

Accumulation and activation of epidermal γδ T cells in a mouse model of chronic dermatitis is not required for the inflammatory phenotype.

Sulcova J, Maddaluno L, Meyer M, Werner S.

Eur J Immunol. 2015 Sep;45(9):2517-28. doi: 10.1002/eji.201545675. Epub 2015 Jul 6.

5.

Mast cells are dispensable in a genetic mouse model of chronic dermatitis.

Sulcova J, Meyer M, Guiducci E, Feyerabend TB, Rodewald HR, Werner S.

Am J Pathol. 2015 Jun;185(6):1575-87. doi: 10.1016/j.ajpath.2015.02.005. Epub 2015 Apr 3.

PMID:
25843682
6.

The role of chronic inflammation in cutaneous fibrosis: fibroblast growth factor receptor deficiency in keratinocytes as an example.

Meyer M, Müller AK, Yang J, Ŝulcová J, Werner S.

J Investig Dermatol Symp Proc. 2011 Dec;15(1):48-52. doi: 10.1038/jidsymp.2011.1. Review.

7.

How short-term transdermal treatment of men with 7-oxo-dehydroepiandrosterone influence thyroid function.

Hampl R, Sulcová J, Bílek R, Hill M.

Physiol Res. 2006;55(1):49-54. Epub 2005 Apr 26.

9.

Decrease in serum dehydroepiandrosterone level after fenofibrate treatment in males with hyperlipidemia.

Sulcová J, Stulc T, Hill M, Hampl R, Masek Z, Vondra K, Ceska R.

Physiol Res. 2005;54(2):151-7.

10.

Pregnanolone isomers, pregnenolone and their polar conjugates around parturition.

Klak J, Hill M, Parízek A, Havlíková H, Bicíková M, Hampl R, Fait T, Sulcová J, Pouzar V, Kancheva R, Stárka L.

Physiol Res. 2003;52(2):211-21.

11.

Leptin levels in obese children: effects of gender, weight reduction and androgens.

Pilcová R, Sulcová J, Hill M, Bláha P, Lisá L.

Physiol Res. 2003;52(1):53-60.

12.

Neuroactive steroids, their precursors and polar conjugates during parturition and postpartum in maternal and umbilical blood: 3.3beta-hydroxy-5-ene steroids.

Hill M, Parízek A, Klak J, Hampl R, Sulcová J, Havlíková H, Lapcík O, Bicíková M, Fait T, Kancheva R, Cibula D, Pouzar V, Meloun M, Stárka L.

J Steroid Biochem Mol Biol. 2002 Oct;82(2-3):241-50.

PMID:
12477491
13.

[Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].

Vrbíková J, Hill M, Stárka L, Cibula D, Snajderová M, Sulcová J, Vondra K, Bendlová B.

Cas Lek Cesk. 2001 Nov 8;140(22):688-94. Czech.

PMID:
11789058
14.

Neuroactive steroids, their precursors and polar conjugates during parturition and postpartum in maternal blood: 2. Time profiles of pregnanolone isomers.

Hill M, Bicíková M, Parízek A, Havlíková H, Klak J, Fajt T, Meloun M, Cibula D, Cegan A, Sulcová J, Hampl R, Stárka L.

J Steroid Biochem Mol Biol. 2001 Jul;78(1):51-7.

PMID:
11530284
15.

The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome.

Vrbíková J, Hill M, Stárka L, Cibula D, Bendlová B, Vondra K, Sulcová J, Snajderová M.

Eur J Endocrinol. 2001 Jun;144(6):619-28.

16.

Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome.

Hampl R, Snajderova M, Lebl J, Lisa L, Dvorakova M, Hill M, Sulcova J, Starka L.

Endocr Regul. 2001 Mar;35(1):17-24.

PMID:
11308992
17.

Effects of transdermal application of 7-oxo-DHEA on the levels of steroid hormones, gonadotropins and lipids in healthy men.

Sulcová J, Hill M, Masek Z, Ceska R, Novácek A, Hampl R, Stárka L.

Physiol Res. 2001;50(1):9-18.

18.

Neuroactive steroids, their precursors, and polar conjugates during parturition and postpartum in maternal and umbilical blood: 1. Identification and simultaneous determination of pregnanolone isomers.

Hill M, Parízek A, Bicíková M, Havlíková H, Klak J, Fait T, Cibula D, Hampl R, Cegan A, Sulcová J, Stárka L.

J Steroid Biochem Mol Biol. 2000 Dec 31;75(4-5):237-44.

PMID:
11282277
19.

[Derivatives of dehydroepiandrosterone and their changes during a one-day starvation test].

Matoulek M, Hampl R, Svacina S, Sulcová J, Haas T.

Cas Lek Cesk. 2000 Dec 6;139(24):772-5. Czech.

PMID:
11262916
20.

Effects of transdermal application of DHEA on the levels of steroids, gonadotropins and lipids in men.

Sulcová J, Hill M, Hampl R, Masek Z, Novácek A, Ceska R, Stárka L.

Physiol Res. 2000;49(6):685-93.

21.

An analysis of the relationship between insulin resistance and the activity of steroid C17,20-lyase and 3beta-hydroxysteroid dehydrogenase in ovaries and adrenals in women with polycystic ovary syndrome.

Vrbíklová J, Hill M, Stárka L, Vondra K, Sulcová J, Snajderová M, Cibula D, Pobisová Z, Bendlová B.

Exp Clin Endocrinol Diabetes. 2000;108(7):455-62.

PMID:
11083066
22.

Do DHEA/DHEAS play a protective role in coronary heart disease?

Porsová-Dutoit I, Sulcová J, Stárka L.

Physiol Res. 2000;49 Suppl 1:S43-56. Review.

23.

Elimination of cross-reactivity by addition of an excess of cross-reactant for radioimmunoassay of 17alpha-hydroxypregnenolone.

Hill M, Hampl R, Lukác D, Lapcík O, Pouzar V, Sulcová J.

Steroids. 1999 May;64(5):341-55.

PMID:
10406484
24.

Age relationships and sex differences in serum levels of pregnenolone and 17-hydroxypregnenolone in healthy subjects.

Hill M, Lukác D, Lapcík O, Sulcová J, Hampl R, Pouzar V, Stárka L.

Clin Chem Lab Med. 1999 Apr;37(4):439-47.

PMID:
10369116
25.
26.

Amniotic fluid 17-hydroxyprogesterone in early pregnancy.

Sulcová J, Macek M, Chudoba D, Hubl W, Hill M, Stárka L.

J Steroid Biochem Mol Biol. 1994 Dec;51(5-6):315-8.

PMID:
7826894
27.

The effect of long-term glucocorticoid therapy on glucocorticoid receptor content and on steroid response to ACTH.

Hampl R, Lapcík O, Sulcová J, Stárka L, Kalvachová B, Dvoráková M, Nĕmcová D, Hoza J.

J Steroid Biochem Mol Biol. 1994 Jan;48(1):81-7.

PMID:
8136309
28.

[Use of modern methods in prenatal diagnosis of congenital adrenal hyperplasia--examination protocol].

Snajderová M, Kolousková S, Sulcová J, Hampl R, Smeral P, Zd'árský E, Stroufová A.

Cesk Pediatr. 1992 Jul;47(7):398-400. Czech.

PMID:
1394538
29.

Serum levels of steroid hormones in men with varicocele and oligospermia as compared to normozoospermic men.

Hampl R, Lachman M, Novák Z, Sulcová J, Stárka L.

Exp Clin Endocrinol. 1992;100(3):117-9.

PMID:
1305061
30.

[Determination of steroid hormones in the amniotic fluid in prenatal genetic diagnosis].

Dvorák P, Macek M, Hampl R, Sulcová J, Burjanková J, Stárka L.

Cas Lek Cesk. 1991 Feb 15;130(7):206-9. Czech.

PMID:
1826462
31.

11 beta-hydroxyandrostenedione in human amniotic fluid.

Hampl R, Sulcová J, Zwinger A, Stárka L.

Exp Clin Endocrinol. 1990 Dec;96(3):325-7.

PMID:
2083574
32.

[Diagnosis of the heterozygote carrier state in 21-hydroxylase deficiency using steroids].

Sulcová J, Hampl R, Foretová L, Vána V, Stárka L.

Vnitr Lek. 1990 Jul;36(7):643-8. Czech.

PMID:
2174197
33.

[Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].

Sulcová J, Lisá L, Dvorák P, Hampl R, Stárka L.

Cesk Pediatr. 1990 Jun;45(6):353-6. Czech.

PMID:
2289256
34.

Daily profiles of salivary cortisol in hydrocortisone treated children with congenital adrenal hyperplasia.

Hampl R, Foretová L, Sulcová J, Stárka L.

Eur J Pediatr. 1990 Jan;149(4):232-4.

PMID:
2303071
35.

[Neonatal levels of 17-hydroxyprogesterone--early diagnosis of adrenogenital syndrome].

Sulcová J, Tichá H, Wiererová O.

Cesk Pediatr. 1989 Dec;44(12):716-8. Czech.

PMID:
2636556
36.

[Hormone levels in granulosa tumors of the ovary].

Jirásek JE, Zwinger A, Stroufová A, Sulcová J.

Cesk Gynekol. 1989 Jul;54(6):446-8. Czech. No abstract available.

PMID:
2791024
37.

Hormonal changes in tamoxifen treated men with idiopathic oligozoospermia.

Hampl R, Heresová J, Lachman M, Sulcová J, Stárka L.

Exp Clin Endocrinol. 1988 Dec;92(2):211-6.

PMID:
3243340
38.

[Extra-gonadal sources of steroidal sex hormones in man].

Stárka L, Hampl R, Sulcová J, Zvĕrina J, Raboch J, Kobilková J.

Vnitr Lek. 1988 Nov;34(11):1057-61. Czech. No abstract available.

PMID:
3206818
39.

[Treatment of oligozoospermia with tamoxifen].

Heresová J, Hampl R, Stárka L, Lachman M, Mellan J, Sulcová J.

Cesk Gynekol. 1988 Mar;53(3):185-91. Czech. No abstract available.

PMID:
3383255
40.

Steroid and steroid regulating hormones in human male castrates.

Hampl R, Zvĕrina J, Sulcová J, Stárka L.

Exp Clin Endocrinol. 1988 Mar;92(3):257-61.

PMID:
3150955
41.

Radioimmunoassay of 11 beta-hydroxyandrostenedione in laboratory diagnostics of selected endocrine disorders.

Putz Z, Hampl R, Velemínský J, Kreze A, Sulcová J, Stárka L.

J Clin Chem Clin Biochem. 1987 Oct;25(10):723-7.

PMID:
3694130
42.

[Levels of hormonal substances in the serum (plasma) and urine of old people. II. Tests with LHRH, TRH, ACTH, metyrapone, TSH and HCG].

Dolecek R, Burejsa B, Hampl R, Putz Z, Stárka L, Safarcík K, Sulcová J, Vavros B, Velemínský J, Závada M.

Cas Lek Cesk. 1984 Jul 6;123(27):825-31. Czech. No abstract available.

PMID:
6488252
43.

[Levels of hormonal substances in the serum (plasma) in old age. I].

Dolecek R, Burejsa B, Hampl R, Kubis M, Putz Z, Stárka L, Safarcík K, Sajnar J, Sulcová J, Velemínský J, et al.

Cas Lek Cesk. 1983 Jul 8;122(27):850-6. Czech. No abstract available.

PMID:
6616543
44.

Metabolism of C19-delta 5-3 beta-hydroxysteroids in the term human amnion.

Sulcová J, Stárka L, Jirásek JE.

Endocrinol Exp. 1982 Mar;16(1):9-17.

PMID:
6461542
45.

Age and sex differences in the metabolism of C19-delta5-steroids in human amniotic epithelium.

Sulcová J, Stárka L, Jirásek JE.

J Dev Physiol. 1980 Dec;2(6):389-99.

PMID:
6455466
46.

The development of the androgen metabolizing activity in the human amniotic epithelium.

Sulcová J, Jirásek JE, Dvorák P, Stárka L.

J Steroid Biochem. 1980 Jan;12:89-93. No abstract available.

PMID:
6448325
47.

19-Nortestosterone in mouse kidney.

Sulcová J, Rafter J, Stárka L.

Endocrinol Exp. 1979;13(4):225-35.

PMID:
316386
48.

Androgen metabolism in the epithelium of the bovine cornea.

Ploc I, Sulcová J, Stárka L.

Endokrinologie. 1978 Nov;72(3):327-33.

PMID:
744178
49.

Peripheral conversion and uptake of androgens in a XXY-man with Klinefelter's syndrome.

Sulcová J, Jirásek JE, Neuwirth J, Raboch J, Stárka L.

Endokrinologie. 1978 Nov;72(3):304-10.

PMID:
744177
50.

[Conversion and uptake of androgens in the periphery of an XXY-male (author's transl)].

Sulcová J, Jirásek JE, Neuwirth J, Raboch J, Stárka L.

Cas Lek Cesk. 1978 May 26;117(21):664-7. Czech. No abstract available.

PMID:
667903

Supplemental Content

Loading ...
Support Center